MSN Group launches Fesobig to treat urinary incontinence and overactive bladder EP News Bureau Mar 16, 2023 It is first-line therapy recommended by various international treatment guideline for overactive bladder (OAB)
Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release… EP News Bureau Jan 9, 2023 The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Toviaz Extended-Release tablets, 4 mg…
